TW202222299A - 製備大麻素之方法 - Google Patents
製備大麻素之方法 Download PDFInfo
- Publication number
- TW202222299A TW202222299A TW110132437A TW110132437A TW202222299A TW 202222299 A TW202222299 A TW 202222299A TW 110132437 A TW110132437 A TW 110132437A TW 110132437 A TW110132437 A TW 110132437A TW 202222299 A TW202222299 A TW 202222299A
- Authority
- TW
- Taiwan
- Prior art keywords
- cbd
- cannabidiol
- solvent
- winterization
- filter aid
- Prior art date
Links
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D9/00—Crystallisation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D11/00—Solvent extraction
- B01D11/02—Solvent extraction of solids
- B01D11/0288—Applications, solvents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/348—Cannabaceae
- A61K36/3482—Cannabis
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D11/00—Solvent extraction
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D11/00—Solvent extraction
- B01D11/02—Solvent extraction of solids
- B01D11/0203—Solvent extraction of solids with a supercritical fluid
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D11/00—Solvent extraction
- B01D11/02—Solvent extraction of solids
- B01D11/028—Flow sheets
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D11/00—Solvent extraction
- B01D11/04—Solvent extraction of solutions which are liquid
- B01D11/0492—Applications, solvents used
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D9/00—Crystallisation
- B01D9/0004—Crystallisation cooling by heat exchange
- B01D9/0013—Crystallisation cooling by heat exchange by indirect heat exchange
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D9/00—Crystallisation
- B01D9/0036—Crystallisation on to a bed of product crystals; Seeding
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D9/00—Crystallisation
- B01D9/004—Fractional crystallisation; Fractionating or rectifying columns
- B01D9/0045—Washing of crystals, e.g. in wash columns
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
- C07C39/23—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing six-membered aromatic rings and other rings, with unsaturation outside the aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/55—Liquid-liquid separation; Phase separation
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Physics & Mathematics (AREA)
- Thermal Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2013765.9 | 2020-09-02 | ||
| GBGB2013765.9A GB202013765D0 (en) | 2020-09-02 | 2020-09-02 | Method of preparing cannabinoids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW202222299A true TW202222299A (zh) | 2022-06-16 |
Family
ID=72749568
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW110132437A TW202222299A (zh) | 2020-09-02 | 2021-09-01 | 製備大麻素之方法 |
Country Status (12)
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2531282A (en) | 2014-10-14 | 2016-04-20 | Gw Pharma Ltd | Use of cannabinoids in the treatment of epilepsy |
| GB2564383B (en) | 2017-06-23 | 2021-04-21 | Gw Res Ltd | Use of cannabidiol in the treatment of tumours assoicated with Tuberous Sclerosis Complex |
| GB2568929A (en) | 2017-12-01 | 2019-06-05 | Gw Res Ltd | Use of cannabinoids in the treatment of epilepsy |
| GB201916846D0 (en) | 2019-11-19 | 2020-01-01 | Gw Res Ltd | Cannabidiol-type cannabinoid compound |
| GB201916849D0 (en) | 2019-11-19 | 2020-01-01 | Gw Res Ltd | Cannabidiol-type cannabinoid compound |
| GB201916974D0 (en) | 2019-11-21 | 2020-01-08 | Gw Res Ltd | Cannabidol-type cannabinoid compound |
| GB202009321D0 (en) | 2020-06-18 | 2020-08-05 | Gw Res Ltd | Use of cannabinoids in the treatment of epilepsy |
| GB2597321A (en) | 2020-07-20 | 2022-01-26 | Gw Res Ltd | Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities |
| EP4006006A1 (en) * | 2020-11-27 | 2022-06-01 | Bridge Farm Nurseries Limited | Production of cannabidiol from hemp using subcritical liquid carbon dioxide |
| GB2602019A (en) | 2020-12-15 | 2022-06-22 | Gw Res Ltd | Cannabinoid derivative as a pharmaceutically active compound and method of preparation thereof |
| CA3264785A1 (en) | 2022-08-12 | 2024-02-15 | Jazz Pharmaceuticals Research Uk Limited | ORAL SOLID DOSAGE FORMS CONTAINING CANNABINOIDS |
| GB202416518D0 (en) | 2024-11-08 | 2024-12-25 | Jazz Pharmaceuticals Research Uk Ltd | Combination therapy |
Family Cites Families (90)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000078979A (ja) | 1998-09-04 | 2000-03-21 | Taisho Pharmaceut Co Ltd | テトラヒドロカンナビノール酸シンターゼ遺伝子 |
| JP2001029082A (ja) | 1999-07-22 | 2001-02-06 | Yukihiro Masayama | カンナビジオール酸シンターゼをコードするdna |
| DE10051427C1 (de) | 2000-10-17 | 2002-06-13 | Adam Mueller | Verfahren zur Herstellung eines Tetrahydrocannabinol- und Cannabidiol-haltigen Extraktes aus Cannabis-Pflanzenmaterial sowie Cannabis-Extrakte |
| DK1361864T3 (en) | 2001-02-14 | 2014-03-03 | Gw Pharma Ltd | FLYLDENDE SPRAY FORMULATIONS FOR buccal administration of cannabinoids |
| US10538373B2 (en) | 2002-08-14 | 2020-01-21 | Gw Pharma Limited | Pharmaceutical formulation |
| MXPA05001621A (es) | 2002-08-14 | 2005-08-19 | Gw Pharma Ltd | Extraccion de cannabinoides farmaceuticamente activos de materiales vegetales. |
| GB2393182B (en) | 2002-09-23 | 2007-03-14 | Gw Pharma Ltd | Method of preparing cannabidiol from plant material |
| CN101193884A (zh) | 2005-06-13 | 2008-06-04 | 惠氏公司 | 微管蛋白抑制剂和其制备方法 |
| US8911751B2 (en) * | 2005-10-11 | 2014-12-16 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Compositions for nasal delivery |
| MY148798A (en) * | 2005-11-08 | 2013-05-31 | Suntory Holdings Ltd | Method of refining episesamin |
| KR101650584B1 (ko) * | 2007-08-31 | 2016-08-23 | 디에스엠 아이피 어셋츠 비.브이. | 다중불포화된 지방산 함유 고체 지방 조성물 및 그의 용도 및 생산 |
| GB2456183A (en) | 2008-01-04 | 2009-07-08 | Gw Pharma Ltd | Anti-psychotic composition comprising cannabinoids and anti-psychotic medicament |
| GB2471987B (en) | 2008-06-04 | 2012-02-22 | Gw Pharma Ltd | Anti-tumoural effects of cannabinoid combinations |
| GB2475183B (en) | 2008-06-04 | 2011-11-23 | Gw Pharma Ltd | Cannabinoids in combination with non-cannabinoid chemotherapeutic agent that are selective estrogen receptor modulators |
| GB2478595B (en) | 2010-03-12 | 2018-04-04 | Gw Pharma Ltd | Phytocannabinoids in the treatment of glioma |
| TWI583374B (zh) | 2010-03-30 | 2017-05-21 | Gw伐瑪有限公司 | 使用植物大麻素次大麻二酚(cbdv)來治療癲癇之用途 |
| GB2487712B (en) | 2011-01-04 | 2015-10-28 | Otsuka Pharma Co Ltd | Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard anti-epileptic drug (SAED) in the treatment of epilepsy |
| EP2500072A1 (en) * | 2011-03-15 | 2012-09-19 | LEK Pharmaceuticals d.d. | A novel process of residual solvent removal |
| CN102351628B (zh) * | 2011-08-10 | 2014-04-16 | 济南卡博唐生物科技有限公司 | 从异己烷和甲醇混合溶剂中除去甲醇的方法 |
| GB2495118B (en) | 2011-09-29 | 2016-05-18 | Otsuka Pharma Co Ltd | A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD) |
| US8604062B2 (en) * | 2011-10-20 | 2013-12-10 | Hoffman-La Roche Inc. | Process for the preparation of isoxazolyl-methoxy nicotinic acids |
| GB2504263B (en) | 2012-06-08 | 2015-09-16 | Gw Pharma Ltd | Synergistic therapies for neuroprotection |
| CN102925295A (zh) * | 2012-10-30 | 2013-02-13 | 陕西启源科技发展有限责任公司 | 一种利用餐饮废油生产生物柴油的制备方法 |
| GB2515312A (en) | 2013-06-19 | 2014-12-24 | Gw Pharma Ltd | The use of phytocannabinoids in the treatment of ovarian carcinoma |
| GB2516814B (en) | 2013-06-19 | 2016-08-31 | Otsuka Pharma Co Ltd | Use of phytocannabinoids for increasing radiosensitivity in the treatment of cancer |
| GB2530001B (en) | 2014-06-17 | 2019-01-16 | Gw Pharma Ltd | Use of cannabidiol in the reduction of convulsive seizure frequency in treatment-resistant epilepsy |
| GB2527591A (en) | 2014-06-27 | 2015-12-30 | Gw Pharma Ltd | 7-hydroxy cannabidiol (7-OH-CBD) for use in the treatment of non-alcoholic fatty liver disease (NAFLD) |
| GB2527599A (en) | 2014-06-27 | 2015-12-30 | Gw Pharma Ltd | Use of 7-OH-Cannabidiol (7-OH-CBD) and/or 7-OH-Cannabidivarin (7-OH-CBDV) in the treatment of epilepsy |
| GB2527590A (en) | 2014-06-27 | 2015-12-30 | Otsuka Pharma Co Ltd | Active pharmaceutical ingredient (API) comprising cannabinoids for use in the treatment of cancer |
| GB2531282A (en) | 2014-10-14 | 2016-04-20 | Gw Pharma Ltd | Use of cannabinoids in the treatment of epilepsy |
| GB2531281A (en) | 2014-10-14 | 2016-04-20 | Gw Pharma Ltd | Use of cannabidiol in the treatment of intractable epilepsy |
| GB2531283A (en) | 2014-10-14 | 2016-04-20 | Gw Pharma Ltd | Use of cannabidiols in the treatment of degenerative skeletal muscle diseases |
| GB2531278A (en) | 2014-10-14 | 2016-04-20 | Gw Pharma Ltd | Use of cannabidiol in the treatment of intractable epilepsy |
| GB2531280A (en) | 2014-10-14 | 2016-04-20 | Gw Pharma Ltd | Use of cannabidiol in the treatment of intractable epilepsy |
| US11034639B2 (en) * | 2015-01-22 | 2021-06-15 | Phytoplant Research S.L. | Methods of purifying cannabinoids using liquid:liquid chromatography |
| GB2539472A (en) | 2015-06-17 | 2016-12-21 | Gw Res Ltd | Use of cannabinoids in the treatment of epilepsy |
| GB2541191A (en) | 2015-08-10 | 2017-02-15 | Gw Pharma Ltd | Use of cannabinoids in the treatment of epilepsy |
| GB2542155B (en) | 2015-09-09 | 2018-08-01 | Gw Pharma Ltd | Use of cannabidiol in the treatment of mental disorders |
| GB2542797A (en) | 2015-09-29 | 2017-04-05 | Gw Pharma Ltd | Use of cannabinoids in the treatment of inflammatory skin diseases |
| GB2548873B (en) | 2016-03-31 | 2020-12-02 | Gw Res Ltd | Use of Cannabidiol in the Treatment of SturgeWeber Syndrome |
| GB2551985B (en) | 2016-07-01 | 2019-01-30 | Gw Res Ltd | Novel formulation |
| GB2551986A (en) | 2016-07-01 | 2018-01-10 | Gw Res Ltd | Parenteral formulations |
| GB2551987A (en) | 2016-07-01 | 2018-01-10 | Gw Res Ltd | Oral cannabinoid formulations |
| GB2553139A (en) | 2016-08-25 | 2018-02-28 | Gw Res Ltd | Use of cannabinoids in the treatment of multiple myeloma |
| US10155176B1 (en) | 2016-11-03 | 2018-12-18 | Healer, LLC | Process for the production of a concentrated cannabinoid product |
| GB2557921A (en) | 2016-12-16 | 2018-07-04 | Gw Res Ltd | Use of cannabinoids in the treatment of angelman syndrome |
| GB2559774B (en) | 2017-02-17 | 2021-09-29 | Gw Res Ltd | Oral cannabinoid formulations |
| GB2560019A (en) | 2017-02-27 | 2018-08-29 | Gw Res Ltd | Use of cannabinoids in the treatment of leukaemia |
| CN110678481B (zh) | 2017-03-16 | 2023-10-31 | 伊沃芙生物制品公司 | 用于纯化白蛋白的方法 |
| CN107011125B (zh) * | 2017-05-06 | 2020-07-28 | 云南汉木森生物科技有限责任公司 | 一种富集大麻二酚的方法 |
| GB2564383B (en) | 2017-06-23 | 2021-04-21 | Gw Res Ltd | Use of cannabidiol in the treatment of tumours assoicated with Tuberous Sclerosis Complex |
| US9919241B1 (en) | 2017-06-27 | 2018-03-20 | Entheo Gardens Inc | Extraction method |
| US10189762B1 (en) | 2017-07-07 | 2019-01-29 | Orochem Technologies, Inc. | Process for purification and separation of cannabinoids, from dried hemp and cannabis leaves |
| IT201700085508A1 (it) | 2017-07-26 | 2019-01-26 | Inalco S R L | Metodo per la produzione di cannabinoidi da varietà di canapa industriale |
| GB201715919D0 (en) | 2017-09-29 | 2017-11-15 | Gw Res Ltd | use of cannabinoids in the treatment of epilepsy |
| GB2568471B (en) | 2017-11-15 | 2022-04-13 | Gw Res Ltd | Use of cannabinoids in the treatment of epilepsy |
| GB2568929A (en) | 2017-12-01 | 2019-06-05 | Gw Res Ltd | Use of cannabinoids in the treatment of epilepsy |
| GB2572125B (en) | 2018-01-03 | 2021-01-13 | Gw Res Ltd | Pharmaceutical |
| GB2572126B (en) | 2018-01-03 | 2021-01-13 | Gw Res Ltd | Pharmaceutical |
| GB2569961B (en) | 2018-01-03 | 2021-12-22 | Gw Res Ltd | Pharmaceutical |
| GB2572737A (en) | 2018-01-24 | 2019-10-16 | Gw Res Ltd | Use of cannabinoids in the treatment of epilepsy |
| WO2019195752A1 (en) * | 2018-04-05 | 2019-10-10 | Canopy Holdings, LLC | Hemp powder |
| GB201806953D0 (en) | 2018-04-27 | 2018-06-13 | Gw Res Ltd | Cannabidiol Preparations |
| WO2020028198A1 (en) * | 2018-08-03 | 2020-02-06 | Biomass Oil Separation Solutions, Llc | Processes and apparatus for extraction of substances and enriched extracts from plant material |
| GB2579179A (en) | 2018-11-21 | 2020-06-17 | Gw Res Ltd | Cannabidiol-type cannabinoid compound |
| CA3138732A1 (en) | 2018-11-30 | 2020-06-04 | Canopy Growth Corporation | Water-soluble formulations of cannabinoids or cannabis-derived compounds, methods of making and use |
| GB2580881A (en) | 2018-11-30 | 2020-08-05 | Gw Res Ltd | Use of cannabinoids in the treatment of epilepsy |
| US10413845B1 (en) * | 2018-12-14 | 2019-09-17 | Socati Technologies | Processes for solvent extraction of cannabinoids, terpenes and flavonoids from biomass |
| US10414709B1 (en) * | 2018-12-14 | 2019-09-17 | Socati Technologies | Processes for solvent extraction of cannabinoids, terpenes and flavonoids from biomass |
| GB2580653A (en) | 2019-01-21 | 2020-07-29 | Gw Res Ltd | Use of cannabinoids in the treatment of comorbidities associated with epilepsy |
| GB2581517A (en) | 2019-02-22 | 2020-08-26 | Gw Res Ltd | Use of cannabinoids in the treatment of epilepsy |
| GB2581987B (en) | 2019-03-06 | 2021-11-17 | Gw Res Ltd | Use of cannabidiol in combination with antibiotics |
| GB2584140A (en) | 2019-05-23 | 2020-11-25 | Gw Res Ltd | Use of cannabidiol in the treatment of epileptic spasms |
| GB2584341B (en) | 2019-05-31 | 2023-03-01 | Gw Res Ltd | Cannabinoid formulations |
| CN110304994B (zh) * | 2019-07-01 | 2022-04-01 | 吴平 | 一种从工业大麻中提取高纯度大麻二酚的方法 |
| GB201910389D0 (en) | 2019-07-19 | 2019-09-04 | Gw Pharma Ltd | Novel compounds, methods for their manufacture, and uses thereof |
| GB2586026A (en) | 2019-07-29 | 2021-02-03 | Gw Res Ltd | Use of cannabidol in the treatment of Dravet syndrome |
| GB2588576A (en) | 2019-08-27 | 2021-05-05 | Gw Res Ltd | Use of cannabinoids in the treatment of dyskinesia associated with Parkinson's disease |
| GB2588461A (en) | 2019-10-25 | 2021-04-28 | Gw Res Ltd | Use of cannabidiol preparations in the treatment of absence epilepsy |
| GB2588457B (en) | 2019-10-25 | 2022-12-21 | Gw Res Ltd | Cannabinoid compound |
| GB201916846D0 (en) | 2019-11-19 | 2020-01-01 | Gw Res Ltd | Cannabidiol-type cannabinoid compound |
| GB201916849D0 (en) | 2019-11-19 | 2020-01-01 | Gw Res Ltd | Cannabidiol-type cannabinoid compound |
| GB201916974D0 (en) | 2019-11-21 | 2020-01-08 | Gw Res Ltd | Cannabidol-type cannabinoid compound |
| GB201916977D0 (en) | 2019-11-21 | 2020-01-08 | Gw Res Ltd | Cannibidol-type cannabinoid compound |
| GB201918846D0 (en) | 2019-12-19 | 2020-02-05 | Gw Res Ltd | Oral cannabinoid formulations |
| GB202002754D0 (en) | 2020-02-27 | 2020-04-15 | Gw Res Ltd | Methods of treating tuberous sclerosis complex with cannabidiol and everolimus |
| US20210370198A1 (en) * | 2020-05-29 | 2021-12-02 | Chemtor, Lp | Purification and extraction of cannabinoids |
| US20220087951A1 (en) | 2020-09-18 | 2022-03-24 | GW Research Limited | Use of cannabinoids in the treatment of epilepsy |
| US11160757B1 (en) | 2020-10-12 | 2021-11-02 | GW Research Limited | pH dependent release coated microparticle cannabinoid formulations |
| US11815187B2 (en) | 2022-01-26 | 2023-11-14 | Maag Germany Gmbh | 3-port valve |
-
2020
- 2020-09-02 GB GBGB2013765.9A patent/GB202013765D0/en not_active Ceased
-
2021
- 2021-08-27 CA CA3190849A patent/CA3190849A1/en active Pending
- 2021-08-27 KR KR1020237011264A patent/KR20230061484A/ko active Pending
- 2021-08-27 WO PCT/EP2021/073804 patent/WO2022049007A1/en not_active Ceased
- 2021-08-27 JP JP2023514802A patent/JP7763246B2/ja active Active
- 2021-08-27 CN CN202180054371.6A patent/CN116056773B/zh active Active
- 2021-08-27 AU AU2021338469A patent/AU2021338469A1/en active Pending
- 2021-08-27 US US18/043,810 patent/US12539472B2/en active Active
- 2021-08-27 EP EP21772706.4A patent/EP4208273A1/en active Pending
- 2021-08-27 MX MX2023002535A patent/MX2023002535A/es unknown
- 2021-08-31 GB GB2112397.1A patent/GB2600528A/en not_active Withdrawn
- 2021-09-01 TW TW110132437A patent/TW202222299A/zh unknown
- 2021-09-02 PY PY202102175980A patent/PY2175980A/es unknown
-
2025
- 2025-12-24 US US19/432,540 patent/US20260166448A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20240293762A1 (en) | 2024-09-05 |
| US20260166448A1 (en) | 2026-06-18 |
| MX2023002535A (es) | 2023-03-14 |
| EP4208273A1 (en) | 2023-07-12 |
| AU2021338469A1 (en) | 2023-03-23 |
| JP7763246B2 (ja) | 2025-10-31 |
| GB202013765D0 (en) | 2020-10-14 |
| KR20230061484A (ko) | 2023-05-08 |
| GB2600528A (en) | 2022-05-04 |
| CN116056773B (zh) | 2026-07-24 |
| JP2023539898A (ja) | 2023-09-20 |
| CA3190849A1 (en) | 2022-03-10 |
| WO2022049007A1 (en) | 2022-03-10 |
| GB202112397D0 (en) | 2021-10-13 |
| US12539472B2 (en) | 2026-02-03 |
| PY2175980A (es) | 2022-04-18 |
| CN116056773A (zh) | 2023-05-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7763246B2 (ja) | カンナビノイドの調製方法 | |
| AU2003253002B2 (en) | Extraction of pharmaceutically active cannabinoids from plant materials | |
| EP4181898A1 (en) | Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities | |
| KR102813925B1 (ko) | 포도 및 블루베리 혼합물을 포함하는 특수한 영양용 또는 치료용 제제 | |
| JP7408045B2 (ja) | 非向精神性カンナビノイドを含有する包接物及びその調製方法 | |
| Khokar et al. | Anti-Alzheimer potential of a waste by-product (peel) of Omani pomegranate fruits: Quantification of phenolic compounds, in-vitro antioxidant, anti-cholinesterase and in-silico studies | |
| WO2020168421A1 (en) | Cyclodextrin inclusion complexes of cannabis extracts | |
| WO2020044119A2 (en) | Oral formulations of lavender and cannabinoids | |
| CN114502147A (zh) | 包含黄体素和玉米黄质的具有增强的生物利用度的叶黄素组合物 | |
| WO2006115307A1 (en) | Method of extracting ginsengnoside rg2m, pharmaceutical composition including ginsengnoside rg2, and uses thereof | |
| Xu et al. | Safety evaluation of meso-zeaxanthin | |
| Chen et al. | Lutein attenuated methylglyoxal‐induced oxidative damage and apoptosis in PC12 cells via the PI3K/Akt signaling pathway | |
| Górnaś et al. | Cranberry (Vaccinium macrocarpon Aiton) seeds: An exceptional source of tocotrienols | |
| Sidhartha et al. | Phytochemical screening, antioxidant and antifungal activity test of binahong leaf extract (Anredera cordifolia (Ten.) Steenis) | |
| JP2026501968A (ja) | カンナビノイド組成物、ならびに神経変性疾患または障害及びがんの治療におけるその使用 | |
| Chen et al. | The primary neurotoxic factor, Lansamide I, from Clausena lansium fruits and metabolic dysfunction invoked | |
| EP1491191A1 (de) | Extrakte von Litchi sinensis enthaltend oligomere Proanthocyanidine | |
| Bueno et al. | In silico studies, chemical composition, antibacterial activity and in vitro antigen-induced phagocytosis of Stryphnodendron adstringens (Mart.) Coville | |
| KR20260044829A (ko) | 대마 초임계 추출물을 포함하는 신경세포 보호용 조성물 | |
| JP2000116356A (ja) | 抗アレルギー食品及び抗アレルギー剤 | |
| US20250195546A1 (en) | Cannabinoid-containing compositions | |
| US11478521B2 (en) | Methods for preparation of cannabis oil extracts and compositions | |
| WO2025231524A1 (en) | Cannabinoid compositions | |
| WO2022017925A1 (en) | Use of cannabidiol in the treatment of seizures associated with multifocal epilepsy syndrome | |
| WO2022017927A1 (en) | Use of cannabidiol in the treatment of seizures associated with perisylvian fissure syndrome |